O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension
Received 1 July 2009; accepted 28 September 2009.
Abstract
O-Linked attachment of β-N-acetyl-glucosamine (O-GlcNAc) on serine and threonine residues of nuclear and cytoplasmic proteins is a highly dynamic posttranslational modification that plays a key role in signal transduction pathways. Preliminary data show that O-GlcNAcylation may represent a key regulatory mechanism in the vasculature, modulating contractile and relaxant responses. Proteins with an important role in vascular function, such as endothelial nitric oxide synthase, sarcoplasmic reticulum Ca2+-ATPase, protein kinase C, mitogen-activated protein kinases, and proteins involved in cytoskeleton regulation and microtubule assembly are targets for O-GlcNAcylation, indicating that this posttranslational modification may play an important role in vascular reactivity. Here, we will focus on a few specific pathways that contribute to vascular function and cardiovascular disease–associated vascular dysfunction, and the implications of their modification by O-GlcNAc. New chemical tools have been developed to detect and study O-GlcNAcylation, including inhibitors of O-GlcNAc enzymes, chemoenzymatic tagging methods, and quantitative proteomics strategies; these will also be briefly addressed. An exciting challenge in the future will be to better understand the cellular dynamics of this posttranslational modification, as well as the signaling pathways and mechanisms by which O-GlcNAc is regulated on specific proteins in the vasculature in health and disease.
aDepartment of Physiology, Medical College of Georgia, Augusta, GA, USA
bDepartment of Surgery, Medical College of Georgia, Augusta, GA, USA
cDepartment of Pharmacology, University of Sao Paulo, Sao Paulo, SP, Brazil
Corresponding author: Rita C Tostes, Department of Physiology, Medical College of Georgia, 1120 Fifteenth Street, CA-2095, Augusta, GA 30912-3000. Tel: 706-721-1866; fax: 706-721-7299.
Supported by the National Institutes of Health and Cardiovascular Discovery Institute, EUA and CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), Brazil.